Dosch et al. [99] demonstrated that in pancreatic cancer, CAAs produce interleukin-6 (IL-6), which triggers the activation of the STAT3 signaling pathway in tumor cells. This evidence concerns the gene IL6 and familial pancreatic carcinoma.